Evidence map›Paper›PMID 35387495›Full record

ReviewStroke2022

Neuroinflammation, Stroke, Blood-Brain Barrier Dysfunction, and Imaging Modalities.

Eduardo Candelario-Jalil, Rick M Dijkhuizen, Tim Magnus

Registry-linked trialOpen access · bronzeAbstract readReview
In one paragraph

Review in Stroke, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07030621 (Efficacy of Semaglutide in Improving Neurological Outcomes After Endovascular Thrombectomy for Acute Ischemic Stroke), which is not on this map. Cited by 555 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
555citing papers in PubMed, 5 pooled it
60.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07030621 phase3not yet recruitingnot on this mapstarted 2025, after this paper: background citation

Efficacy of Semaglutide in Improving Neurological Outcomes After Endovascular Thrombectomy for Acute Ischemic Stroke: A Randomized Double-Blind Controlled Trial

TypeinterventionalSponsorRenJi HospitalRan2025 to 2028Enrolled436ConditionsAcute Ischemic StrokeArmsSemaglutide 0.5 mg, Normal Saline
3 · Its place in the literature

Who cites it

555 citing papers in PubMed, 5 syntheses or guidelines pooled it, 791 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Trial
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review

495 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 3 countries.

Eduardo Candelario-JalilDepartment of Neuroscience, McKnight Brain Institute, University of Florida, Gainesville (E.C-J).ORCID 0000-0003-3631-1989
Rick M DijkhuizenBiomedical MR Imaging and Spectroscopy Group, Center for Image Sciences, University Medical Center Utrecht, the Netherlands (R.M.D.).ORCID 0000-0002-4623-4078
Tim MagnusDepartment of Neurology, University Medical Center Hamburg-Eppendorf, Germany (T.M.).
Allen Institute for Brain Science · USLaboratoire d’Imagerie Biomédicale · FRUniversität Hamburg · DE

Funding

Multi-pronged Approach to Recalibrating the Inflammatory Cascade in Ischemic Stroke with BET blockadeR01NS109816 · NINDS · UNIVERSITY OF FLORIDA · PI CANDELARIO-JALIL, EDUARDO JESUS · 2019 to 2023
$1.9M
Neurovascular Protection by Adropin in Ischemic StrokeR01NS103094 · NINDS · UNIVERSITY OF FLORIDA · PI CANDELARIO-JALIL, EDUARDO JESUS · 2018 to 2021
$1.5M
NINDS NIH HHS R01 NS103094NINDS NIH HHS R01 NS109816
6 · The paper itself

Abstract

Maintaining blood-brain barrier (BBB) integrity is crucial for the homeostasis of the central nervous system. Structurally comprising the BBB, brain endothelial cells interact with pericytes, astrocytes, neurons, microglia, and perivascular macrophages in the neurovascular unit. Brain ischemia unleashes a profound neuroinflammatory response to remove the damaged tissue and prepare the brain for repair. However, the intense neuroinflammation occurring during the acute phase of stroke is associated with BBB breakdown, neuronal injury, and worse neurological outcomes. Here, we critically discuss the role of neuroinflammation in ischemic stroke pathology, focusing on the BBB and the interactions between central nervous system and peripheral immune responses. We highlight inflammation-driven injury mechanisms in stroke, including oxidative stress, increased MMP (matrix metalloproteinase) production, microglial activation, and infiltration of peripheral immune cells into the ischemic tissue. We provide an updated overview of imaging techniques for in vivo detection of BBB permeability, leukocyte infiltration, microglial activation, and upregulation of cell adhesion molecules following ischemic brain injury. We discuss the possibility of clinical implementation of imaging modalities to assess stroke-associated neuroinflammation with the potential to provide image-guided diagnosis and treatment. We summarize the results from several clinical studies evaluating the efficacy of anti-inflammatory interventions in stroke. Although convincing preclinical evidence suggests that neuroinflammation is a promising target for ischemic stroke, thus far, translating these results into the clinical setting has proved difficult. Due to the dual role of inflammation in the progression of ischemic damage, more research is needed to mechanistically understand when the neuroinflammatory response begins the transition from injury to repair. This could have important implications for ischemic stroke treatment by informing time- and context-specific therapeutic interventions.

Indexed as

Ischemic StrokeStrokeBlood-Brain BarrierEndothelial CellsHumansInflammationNeuroinflammatory Diseasesblood-brain barrierimmunityischemic strokemicroglianeuroinflammatory diseases

Identifiers

PMID35387495
PMCPMC9038693
OpenAlexW4224942887

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.